Status:
COMPLETED
A Message Framing Intervention for Increasing Parental Acceptance of Human Papillomavirus Vaccination
Lead Sponsor:
University of Maryland, College Park
Collaborating Sponsors:
National Cancer Institute (NCI)
Conditions:
Cervical Cancer
Anal Cancer
Eligibility:
All Genders
18-99 years
Phase:
NA
Brief Summary
The goal of this study is to determine the effects of message framing (gain vs. loss) on African American parents' acceptance of the HPV vaccine and how such effects are moderated by parents' salient ...
Detailed Description
The goal of this study is to determine the effects of message framing (gain vs. loss) on African American parents' acceptance of the HPV vaccine and how such effects are moderated by parents' salient ...
Eligibility Criteria
Inclusion
- 18 years or older
- Self-identify as African American
- Custodial parent or caretaker of at least one child under the age of 18 who has not been fully vaccinated against HPV.
- Has access to Internet to complete the study
Exclusion
- Younger than 18 years
- Does not self-identify as African American
- Not a custodial parent or caretaker of at least one child under the age of 18 who has not been fully vaccinated against HPV.
- Has no access to Internet to complete the study
Key Trial Info
Start Date :
January 22 2021
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
April 15 2022
Estimated Enrollment :
1170 Patients enrolled
Trial Details
Trial ID
NCT03856437
Start Date
January 22 2021
End Date
April 15 2022
Last Update
March 15 2024
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
University of Maryland
College Park, Maryland, United States, 20742